Applications of europium-doped NaYF₄ (NaYF₄:Eu³⁺) nanoparticles in biomedical fields will inevitably increase their exposure to humans, therefore, the assessment of toxicities must be taken into consideration.
No takes yet. Share an insight, caveat, or question.
Ge et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: